berry, out of curiosity... What are you planning to accomplish with this info? I'm not defending the FDA here, but it seems exhaustive and pointless to cry about spilled milk unless you are actually going to take some sort of action. So do you plan on taking some sort of action? I'm being sincere with this question.
I understand what you're saying, but we're beating a dead horse here. Focusing on it now isn't going to accomplish anything. Time to move forward and get over the past, sucky as it may be.
He used to post here as well, but I think he stopped. He's the same guy a couple of weeks back who stated that more than a million shares of SRPT had been covered in a matter of a few days. He was clearly wrong on that. I wouldn't take what he has to say too seriously. He strikes me as too emotional. (Or maybe just manipulative.)
Given the major hit that the IBB has sustained because of the GILD news and the fact that SRPT has managed to remain stable, I'd say you are correct. Barring the absence of news, we've either reached capitulation or will very soon. Smart folks are accumulating here.
I absolutely agree that he has to stop doing so many calls. What exactly is he hoping to achieve at this point? He needs to focus on the task at hand and that's it.
He discussed the "even more excited about" news at a recent conference. It was in regards to the previously undisclosed targets, Progeria and Pompe Disease.
True. This is likely because most of the boys already lost a fair amount of usable muscle in their legs before beginning the trial. I think the real key to etep's longterm success is keeping the heart muscle strong. I'm guessing that no muscle function had been lost by the time the boys began etep, and we know that none has been lost since. That's a huge win, and one that doesn't get as much recognition as it should. So long as etep continues keeping the heart stable, these boys should live much, much longer, even if they eventually lose the ability to walk.
I'm not alleg, but I'll chime in. NVIV is junk. There are so many better biotechs out there that have just as much reward and far less risk.
Bud did a decent job on predicting movements in SRPT (albeit he was off by a month or two sometimes), but his call for the major markets to crash was way, way off. He started calling that back in February. It's not such a big deal that he's been wrong, but that he's so insistent on thinking he's right, yhat in doing so, anyone blindly following him has lost a ton of money and/or missed out on massive market gains.
Gary, every time you post something like this it goes to show that you really don't understand the market. If Sarepta was worth $31 right now, it wouldn't be trading 70% below that. You're sharing what you think is your fair value. The market, however, disagrees. And the market is all that matters.
Haha. Have you been doing message board searches for the word "assume"? Second time I've seen you mention your distaste for the word.
Um, she's as informed as anyone and is one of the reasons investors first became aware of how successful eteplirsen has been. Think before pointing the finger, jerk.
I highly doubt it's the beginning of the end. The company is clearly on the verge of some pretty big things. So long as AAPL and the SOX continue to soar, so will MU.
I'd wager most shorts even believe the drug works at this point. The anecdotal evidence is just too overwhelming at 3.5 years in. The shorts are simply betting that the FDA will require a full P3 trial, which might be the case. Either way, shares are a good deal at this price, in my opinion.